Humana Stock Forecast
NYSE: HUMHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:03 PM ET · Delayed 15 min
HUM analyst consensus
Consensus (26 analysts)
buy
Avg. price target
$510.83+30.98%
- Strong buy 5
- Buy 14
- Hold 6
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 26 Wall Street analysts covering Humana (2026-11-21), 19 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $510.83, with a high estimate of $602.00 and a low estimate of $280.00. The average target implies upside of 31.0% from the current price of $390.00.
The spread between the highest and lowest targets is 115.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HUM.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 5 | 19% |
| Buy | 14 | 54% |
| Hold | 6 | 23% |
| Sell | 1 | 4% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-21.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $280.00 | -28.21% |
| Average target | $510.83 | +30.98% |
| High target | $602.00 | +54.36% |